181 related articles for article (PubMed ID: 35083867)
1. Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses.
Zhou R; To KK; Peng Q; Chan JM; Huang H; Yang D; Lam BH; Chuang VW; Cai JP; Liu N; Au KK; Tsang OT; Yuen KY; Chen Z
Clin Transl Med; 2022 Jan; 12(1):e720. PubMed ID: 35083867
[No Abstract] [Full Text] [Related]
2. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.
Ai J; Zhang H; Zhang Y; Lin K; Zhang Y; Wu J; Wan Y; Huang Y; Song J; Fu Z; Wang H; Guo J; Jiang N; Fan M; Zhou Y; Zhao Y; Zhang Q; Liu Q; Lv J; Li P; Qiu C; Zhang W
Emerg Microbes Infect; 2022 Dec; 11(1):337-343. PubMed ID: 34935594
[No Abstract] [Full Text] [Related]
3. Metabolic disorders, COVID-19 and vaccine-breakthrough infections.
Stefan N
Nat Rev Endocrinol; 2022 Feb; 18(2):75-76. PubMed ID: 34873287
[TBL] [Abstract][Full Text] [Related]
4. Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma.
Wang Y; Ma Y; Xu Y; Liu J; Li X; Chen Y; Chen Y; Xie J; Xiao L; Xiang Z; Wu F; Huang J
Emerg Microbes Infect; 2022 Dec; 11(1):424-427. PubMed ID: 35001836
[No Abstract] [Full Text] [Related]
5. Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
Schmidt F; Muecksch F; Weisblum Y; Da Silva J; Bednarski E; Cho A; Wang Z; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD
N Engl J Med; 2022 Feb; 386(6):599-601. PubMed ID: 35030645
[No Abstract] [Full Text] [Related]
6. COVID-19 vaccine breakthrough infections.
Gupta RK; Topol EJ
Science; 2021 Dec; 374(6575):1561-1562. PubMed ID: 34941414
[TBL] [Abstract][Full Text] [Related]
7. Omicron sparks a vaccine strategy debate.
Cohen J
Science; 2021 Dec; 374(6575):1544-1545. PubMed ID: 34941399
[No Abstract] [Full Text] [Related]
8. What the Omicron wave is revealing about human immunity.
Willyard C
Nature; 2022 Feb; 602(7895):22-25. PubMed ID: 35110764
[No Abstract] [Full Text] [Related]
9. Could mixing COVID vaccines boost immune response?
Ledford H
Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
[No Abstract] [Full Text] [Related]
10. Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
Kuhlmann C; Mayer CK; Claassen M; Maponga T; Burgers WA; Keeton R; Riou C; Sutherland AD; Suliman T; Shaw ML; Preiser W
Lancet; 2022 Feb; 399(10325):625-626. PubMed ID: 35063123
[No Abstract] [Full Text] [Related]
11. Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant.
Zhang W; Huang L; Ye G; Geng Q; Ikeogu N; Harris M; Dileepan G; Burrack K; Du L; Frosch A; Li F
Cell Mol Immunol; 2022 Mar; 19(3):445-446. PubMed ID: 35075267
[No Abstract] [Full Text] [Related]
12. Omicron likely to weaken COVID vaccine protection.
Callaway E
Nature; 2021 Dec; 600(7889):367-368. PubMed ID: 34880488
[No Abstract] [Full Text] [Related]
13. Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization.
Wang J; Guo C; Cai L; Liao C; Yi H; Li Q; Hu H; Deng Q; Lu Y; Guo Z; Chen Z; Lu J
Front Immunol; 2021; 12():772511. PubMed ID: 34868035
[TBL] [Abstract][Full Text] [Related]
14. Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model.
Chen Y; Li C; Liu F; Ye Z; Song W; Lee ACY; Shuai H; Lu L; To KK; Chan JF; Zhang AJ; Chu H; Yuen KY
Emerg Microbes Infect; 2022 Dec; 11(1):368-383. PubMed ID: 34989330
[TBL] [Abstract][Full Text] [Related]
15. Sequentially immune-induced antibodies could cross-neutralize SARS-CoV-2 variants.
Lv Q; Zhou S; Qi F; Zhang Y; Li F; Liu M; Bao L
Animal Model Exp Med; 2022 Feb; 5(1):89-93. PubMed ID: 35213787
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.
Narowski TM; Raphel K; Adams LE; Huang J; Vielot NA; Jadi R; de Silva AM; Baric RS; Lafleur JE; Premkumar L
Cell Rep; 2022 Feb; 38(5):110336. PubMed ID: 35090596
[TBL] [Abstract][Full Text] [Related]
17. mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant.
Parry H; Tut G; Bruton R; Faustini S; Stephens C; Saunders P; Bentley C; Hilyard K; Brown K; Amirthalingam G; Charlton S; Leung S; Chiplin E; Coombes NS; Bewley KR; Penn EJ; Rowe C; Otter A; Watts R; D'Arcangelo S; Hallis B; Makin A; Richter A; Zuo J; Moss P
Elife; 2021 Sep; 10():. PubMed ID: 34586068
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
Collier AY; McMahan K; Yu J; Tostanoski LH; Aguayo R; Ansel J; Chandrashekar A; Patel S; Apraku Bondzie E; Sellers D; Barrett J; Sanborn O; Wan H; Chang A; Anioke T; Nkolola J; Bradshaw C; Jacob-Dolan C; Feldman J; Gebre M; Borducchi EN; Liu J; Schmidt AG; Suscovich T; Linde C; Alter G; Hacker MR; Barouch DH
JAMA; 2021 Jun; 325(23):2370-2380. PubMed ID: 33983379
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-induced protection in aging adults and pandemic response.
Schenkelberg T
Biochem Biophys Res Commun; 2021 Jan; 538():218-220. PubMed ID: 33213845
[No Abstract] [Full Text] [Related]
20. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.
Jalkanen P; Kolehmainen P; Häkkinen HK; Huttunen M; Tähtinen PA; Lundberg R; Maljanen S; Reinholm A; Tauriainen S; Pakkanen SH; Levonen I; Nousiainen A; Miller T; Välimaa H; Ivaska L; Pasternack A; Naves R; Ritvos O; Österlund P; Kuivanen S; Smura T; Hepojoki J; Vapalahti O; Lempainen J; Kakkola L; Kantele A; Julkunen I
Nat Commun; 2021 Jun; 12(1):3991. PubMed ID: 34183681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
